
Proceedings Paper
Rapid screening test for gestational diabetes: public health need, market requirement, initial product design, and experimental resultsFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Gestational diabetes is a global epidemic where many urban areas in Southeast Asia have found prevalence rates as high
as 20%, exceeding the highest prevalence rates in the developed world. It can have serious and life-threatening
consequences for mothers and babies.
We are developing two variants of a new, simple, low-cost rapid test for screening for gestational diabetes mellitus for
use primarily in low-resource settings. The pair of assays, both semiquantitative rapid diagnostic strip tests for glycated
albumin, require neither fasting nor an oral glucose challenge test. One variant is an extremely simple strip test to
estimate the level of total glycated albumin in blood. The other, which is slightly more complex and expensive, is a test
that determines the ratio of glycated albumin to total albumin. The screening results can be used to refer women to
receive additional care during delivery to avoid birth complications as well as counseling on diet and exercise during and
after pregnancy. Results with the latter test may also be used to start treatment with glucose-lowering drugs. Both assays
will be read visually. We present initial results of a preliminary cost-performance comparison model evaluating the
proposed test versus existing alternatives. We also evaluated user needs and schematic paper microfluidics-based designs
aimed at overcoming the challenge of visualizing relatively narrow differences between normal and elevated levels of
glycated albumin in blood.
Paper Details
Date Published: 13 March 2013
PDF: 21 pages
Proc. SPIE 8615, Microfluidics, BioMEMS, and Medical Microsystems XI, 86150L (13 March 2013); doi: 10.1117/12.2008326
Published in SPIE Proceedings Vol. 8615:
Microfluidics, BioMEMS, and Medical Microsystems XI
Holger Becker; Bonnie L. Gray, Editor(s)
PDF: 21 pages
Proc. SPIE 8615, Microfluidics, BioMEMS, and Medical Microsystems XI, 86150L (13 March 2013); doi: 10.1117/12.2008326
Show Author Affiliations
Roger Peck, PATH (United States)
Elizabeth Abu-Haydar, PATH (United States)
Elizabeth Abu-Haydar, PATH (United States)
Published in SPIE Proceedings Vol. 8615:
Microfluidics, BioMEMS, and Medical Microsystems XI
Holger Becker; Bonnie L. Gray, Editor(s)
© SPIE. Terms of Use
